Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Mise à jour : Il y a 4 ans
Référence : NCT00483574

Femme et Homme

Extrait

This clinical trial will evaluate the safety of two injections of Menactra® Vaccine in subjects at 9 months and at 12 months of age when the second dose is given concomitantly with other pediatric vaccines routinely administered in the US. Safety Objective: To describe the safety profile of two doses of Menactra® Vaccine.


Critère d'inclusion

  • Meningococcal Meningitis ,Measles ,Mumps ,Rubella ,varicella

Liens